Selection and testing of the suitability of antigens for neurodegeneration diagnostics (Q10677): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: summary (P836): The project will provide for the selection and characterisation of antigens for the diagnosis of neurodegenerative diseases and, on the other hand, their commercial availability, possibly their own preparation, the status of intellectual property rights and their intended use for differential diagnosis of the intended diseases. The selected antigens will be further verified on real sample panels with known diagnosis., remove_old_english_transl...) |
(Created claim: summary (P836): The project will include selection and characterisation of antigens for the diagnosis of neurodegenerative diseases, taking into account their commercial availability or possible preparation, the state of intellectual property rights and their intended use for the differential diagnosis of the intended diseases. Selected antigens will be further verified on panels of real samples with a known diagnosis. a., translated_summary) |
||||||||||||||
Property / summary | |||||||||||||||
The project will include selection and characterisation of antigens for the diagnosis of neurodegenerative diseases, taking into account their commercial availability or possible preparation, the state of intellectual property rights and their intended use for the differential diagnosis of the intended diseases. Selected antigens will be further verified on panels of real samples with a known diagnosis. a. (English) | |||||||||||||||
Property / summary: The project will include selection and characterisation of antigens for the diagnosis of neurodegenerative diseases, taking into account their commercial availability or possible preparation, the state of intellectual property rights and their intended use for the differential diagnosis of the intended diseases. Selected antigens will be further verified on panels of real samples with a known diagnosis. a. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / summary: The project will include selection and characterisation of antigens for the diagnosis of neurodegenerative diseases, taking into account their commercial availability or possible preparation, the state of intellectual property rights and their intended use for the differential diagnosis of the intended diseases. Selected antigens will be further verified on panels of real samples with a known diagnosis. a. (English) / qualifier | |||||||||||||||
point in time: 22 October 2020
|
Revision as of 15:18, 22 October 2020
Project in Czech Republic financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | Selection and testing of the suitability of antigens for neurodegeneration diagnostics |
Project in Czech Republic financed by DG Regio |
Statements
189,000.0 Czech koruna
0 references
252,000.0 Czech koruna
0 references
75 percent
0 references
8 March 2017
0 references
31 December 2017
0 references
31 December 2017
0 references
VIDIA spol. s r.o.
0 references
25250
0 references
V rámci projektu bude proveden výběr a charakterizace antigenů pro diagnostiku neurodegenerativních onemocnění, jednak s ohledem na jejich komerční dostupnost, popř. možnou vlastní přípravu, na stav práv duševního vlastnictví a jednak s ohledem na jejich předpokládané využití pro diferenciální diagnostiku zamýšlených onemocnění. Vybrané antigeny budou dále ověřeny na panelech reálných vzorků se známou diagnózou. a. (Czech)
0 references
The project will include selection and characterisation of antigens for the diagnosis of neurodegenerative diseases, taking into account their commercial availability or possible preparation, the state of intellectual property rights and their intended use for the differential diagnosis of the intended diseases. Selected antigens will be further verified on panels of real samples with a known diagnosis. a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_045/0009746
0 references